Avoro Capital Advisors LLC Sarepta Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

$8.3 Billion
Q1 2024

A detailed history of Avoro Capital Advisors LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 4,344,444 shares of SRPT stock, worth $686 Million. This represents 6.78% of its overall portfolio holdings.

Number of Shares

4,344,444

Previous 4,344,444 -0.0%

Holding current value

$686 Million

Previous $419 Million 34.25%

% of portfolio

6.78%

Previous 5.97%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $21.5 Million - $39.9 Million	319,444 Added 7.94%	4,344,444 $419 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $61.8 Million - $74.5 Million	-602,888 Reduced 13.03%	4,025,000 $488 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $104 Million - $154 Million	977,888 Added 26.79%	4,627,888 $530 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $55.8 Million - $74.1 Million	475,000 Added 14.96%	3,650,000 $503 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $16.3 Million - $25.6 Million	-215,000 Reduced 6.34%	3,175,000 $351 Million

Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $16 Million - $22.6 Million	255,000 Added 8.13%	3,390,000 $254 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $631,500 - $904,200	10,000 Added 0.32%	3,135,000 $245 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $48.3 Million - $62.1 Million	625,000 Added 25.0%	3,125,000 $281 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $6.6 Million - $9.25 Million	100,000 Added 4.17%	2,500,000 $231 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $17.3 Million - $21.7 Million	250,000 Added 11.63%	2,400,000 $187 Million
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $28.9 Million - $67.6 Million	400,000 Added 22.86%	2,150,000 $160 Million
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $9.42 Million - $13.4 Million	75,000 Added 4.48%	1,750,000 $298 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $8.37 Million - $15.5 Million	90,000 Added 5.68%	1,675,000 $269 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $14.4 Million - $23 Million	-175,000 Reduced 9.94%	1,585,000 $155 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $6.28 Million - $11.1 Million	82,000 Added 4.89%	1,760,000 $227 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $20.2 Million - $43.6 Million	278,000 Added 19.86%	1,678,000 $126 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $23 Million - $31.1 Million	205,000 Added 17.15%	1,400,000 $213 Million
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $8.53 Million - $12.1 Million	-80,000 Reduced 6.27%	1,195,000 $142 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $32.3 Million - $49.3 Million	331,500 Added 35.14%	1,275,000 $139 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $1.78 Million - $2.49 Million	-15,428 Reduced 1.61%	943,500 $152 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $68.8 Million - $147 Million	958,928 New	958,928 $127 Million

Others Institutions Holding SRPT

# of Institutions

470

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.8B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account

Avoro Capital Advisors LLC Sarepta Therapeutics, Inc. Transaction History